← All stocks

Quince Therapeutics, Inc.

QNCX Net selling
CIK 0001662774 #4870 in the set updated 18 Sep 2026
Bought (120 mo)
$11.88M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$29.23M
$0.00 on a plan · $9.71M straight out of an exercise
Sold at will
$19.52M
32 of 63 sales
Net
−$17.34M
−$7.63M against sales at will

By person

21 insiders · 141 transactions
6.2×

Dirk Thye holds 6.2 times base salary in stock. $3.45M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dirk Thye last reported holding, valued at $3.47, the price Common Stock was last bought or sold at on the open market here, on 26 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PFIZER INC entity
10% owner
$850.00K (1)
$14.87M (1)
−$14.02M
2,879,973
$9.99M
Lamond David
Director
$8.65M (32)
+$8.65M
8,031,665
$27.87M
+120.2%
Lynch Casey
Chief Executive Officer
$4.41M (25)
−$4.41M
1,180,580
$4.10M
−4.8%
Detke Michael J.
Chief Medical Officer
$4.15M (9) scheduled
−$4.15M
140,000
$485.80K
LOWE CHRISTOPHER P.
Interim CEO, COO & CFO
$3.67M (10) scheduled
−$3.67M
265,000
$919.55K
EPIQ Capital Group, LLC entity
IA/Managing Member of 10% Owne
$1.33M (15)
+$1.33M
19,880,610
$68.99M
+0.1%
Holsinger Leslie
EVP, Preclinical Development
$1.23M (6) scheduled
−$1.23M
148,080
$513.84K
McLoughlin Margaret
Director
$19.19K (2)
$691.91K (9) scheduled
−$672.72K
8,000
$27.76K
YOUNG KEVIN
Director
$510.00K (1)
+$510.00K
30,000
$104.10K
Thye Dirk
CEO and CMO
$317.46K (4)
+$317.46K
994,885
$3.45M
+359.9%
Benatti Luca
Director
$173.50K (1)
−$173.50K
39,179
$135.95K
−51.2%
Hannah Brendan
CBO, COO & CCO
$111.72K (7)
+$111.72K
361,827
$1.26M
+218.6%
RYAN UNA S
Director
$48.88K (1)
+$48.88K
2,875
$9.98K
Ryan Charles S.
President
$31.45K (1)
+$31.45K
130,009
$451.13K
+75.5%
McDowell Caryn Gordon
Chief Legal & Adm. Officer
$30.92K (1)
−$30.92K
122,500
$425.08K
Dominy Stephen S.
Chief Scientific Officer
$10.99K (1)
+$10.99K
1,217,086
$4.22M
+0.1%
Monohon Ted
Chief Accounting Officer & VP
$1.83K (1)
−$1.83K
27,440
$95.22K
LAMOND PIERRE
10% owner
2,886,530
$10.02M
Takeda Ventures, Inc. entity
10% owner
2,679,802
$9.30M
Low Philip S
Director
519,283
$1.80M
Smith Karen L.
Chief Medical Officer
24,336
$84.45K

No percentages here. This company's share count has moved by a factor of 160.3 over the window, from 1,017,063 to 163,007,943 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Hannah Brendan
5 Dec 2025
CBO, COO & CCO
Exercised, kept
25,280
$0.94
$23.76K
Hannah Brendan
5 Dec 2025
CBO, COO & CCO
Exercised, kept
2,271
$0.55
$1.25K
Hannah Brendan
4 Jun 2024
CHIEF BUSINESS OFFICER AND COO
Exercised, kept
56,061
$0.55
$30.83K
Thye Dirk
16 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
149,999
$0.94
$141.00K
Thye Dirk
16 Jan 2024
CHIEF EXECUTIVE OFFICER
Exercised, kept
90,531
$0.55
$49.79K
Lynch Casey
18 Nov 2021
Chief Executive Officer
Exercised, kept
60,000
$0.46
$27.60K
LOWE CHRISTOPHER P.
16 Nov 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
LOWE CHRISTOPHER P.
17 Aug 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
LOWE CHRISTOPHER P.
30 Jun 2021
COO & Chief Financial Officer
Exercised, kept
30,000
$2.23
$66.90K
Holsinger Leslie
10 Dec 2020
Executive Vice President
Exercised, kept
3,500
$0.27
$945.00
Detke Michael J.
27 May 2020
Chief Medical Officer
Exercised, kept
5,515
$6.91
$38.11K
Detke Michael J.
2 Apr 2020
Chief Medical Officer
Exercised, kept
5,515
$6.91
$38.11K
Detke Michael J.
7 Feb 2020
Chief Medical Officer
Exercised, kept
17,231
$6.91
$119.07K

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 32
Transactions with no price 0
Shares from compensation/vesting 16,076,553
Sales filed before the plan box existed 31
History held since 9 May 2019